Titlebook: Managing Technology in Healthcare; Eliezer Geisler,Ori Heller Book 1996 Kluwer Academic Publishers 1996 Analysis.Hospital.care program.hea

hysterectomy

An International Comparison of the Approval of New Pharmaceuticals 1988. Our hypothesis is that the timing of approvals will be similar in both countries because of their similar approval processes and objectives. We analyze differences in the delays over time, by the . assessment by the FDA concerning a drug’s innovativeness, and by drug therapeutic category. We

注视

Technology-Based Service Innovation in Hospitals: The Role of Collective and Competitive Strategies difficult to achieve given the costs of innovation, the impacted nature of technical knowledge and learning, institutional pressures for conformity within an industry, and organizational barriers to change.

transient-pain

GILD

表主动

谄媚于人

An International Comparison of the Approval of New Pharmaceuticalsve, and for drugs treating cardiovascular illnesses, the disease group with the highest age-adjusted mortality rate. The observation that one country consistently lagged behind the other in approving new drugs might indicate that the lagging country is either more rigorous, or perhaps less efficient, than the other.

你敢命令

残废的火焰

MUTE

难听的声音

Management of Technology in Health Care: Definitions, Role and Mapping the Fieldcs. For example, some writers in the health care management area dealt with technology as a side issue (Shortell and Kaluzny, 1987). On the other end, writers in the technology management area ventured into health care as an illustrative exercise (for example, Reisman and Kiley, 1973, and Reisman, 1981).